about
Quality of voluntary medical male circumcision services during scale-up: a comparative process evaluation in Kenya, South Africa, Tanzania and Zimbabwe.Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data.Cost analysis of integrating the PrePex medical device into a voluntary medical male circumcision program in ZimbabweCosts and impacts of scaling up voluntary medical male circumcision in Tanzania.Systematic Monitoring of Voluntary Medical Male Circumcision Scale-up: adoption of efficiency elements in Kenya, South Africa, Tanzania, and ZimbabweProvider attitudes toward the voluntary medical male circumcision scale-up in Kenya, South Africa, Tanzania and Zimbabwe.Implications of the fast-evolving scale-up of adult voluntary medical male circumcision for quality of services in South Africa.Work experience, job-fulfillment and burnout among VMMC providers in Kenya, South Africa, Tanzania and Zimbabwe.Voluntary medical male circumcision (VMMC) in Tanzania and Zimbabwe: service delivery intensity and modality and their influence on the age of clients.Surgical efficiencies and quality in the performance of voluntary medical male circumcision (VMMC) procedures in Kenya, South Africa, Tanzania, and Zimbabwe.Voluntary medical male circumcision: strategies for meeting the human resource needs of scale-up in southern and eastern Africa.Voluntary medical male circumcision: matching demand and supply with quality and efficiency in a high-volume campaign in Iringa Region, TanzaniaVoluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa"Man, what took you so long?" Social and individual factors affecting adult attendance at voluntary medical male circumcision services in TanzaniaCost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces.Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting.The Economic and Epidemiological Impact of Focusing Voluntary Medical Male Circumcision for HIV Prevention on Specific Age Groups and Regions in Tanzania.Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography.Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting.Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0.Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.Association between intoxication at last sexual intercourse and unprotected sex among men and women in Uganda.Influence of nativity status on breast cancer risk among US black women.Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy.Participation in research involving novel sampling and study designs to identify acute HIV-1 infection among minority men who have sex with menNatural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitorsPotential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.Lessons learned from scale-up of voluntary medical male circumcision focusing on adolescents: benefits, challenges, and potential opportunities for linkages with adolescent HIV, sexual, and reproductive health services.A multi-disciplinary approach to implementation science: the NIH-PEPFAR PMTCT implementation science alliance.Sexual risk reduction among non-injection drug users: report of a randomized controlled trial.Correction: Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0.Correction: Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting.Correction: Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting.Correction: Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and GeographyCorrection: Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces.Building the evidence base for urgent action: HIV epidemiology and innovative programming for men who have sex with men in sub-Saharan AfricaChanges in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy.The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.Intimate-partner violence and HIV in South African women.
P50
Q30210272-3DC001F6-5615-48A6-8990-86D1EECE0DD6Q31150412-021C93C1-85CF-449F-B477-9443E987E0E6Q33572206-1C4C936D-38E1-40E2-BC9E-0C3C35E1CF59Q33572212-F2BBECDF-7CF5-4209-B5FC-0D4137D44D70Q33572218-B9327156-F331-4932-8C68-15EBF734A566Q33572665-05566E26-20BE-4D4E-BB2C-9A1A6742C136Q33572684-B8DC4B3F-A678-4830-B5DC-C0C2B609B5AAQ33572783-1C787915-C2CD-413A-A816-63BBE7731383Q33573434-9C520A24-A2C0-4688-92ED-575849C498BCQ33573440-49D0F44F-6D82-42D5-AC7F-EE8B94C8D130Q34090894-FA1054CB-3D68-4B95-BA21-ACC051AF881EQ34090906-7F901F77-8B34-4C73-9817-9DBED64F93DEQ34090912-39E39493-011C-41C4-83CB-3A3F7F43B493Q34210400-AFD37A8A-069F-4A22-8415-9E5170B37433Q36074632-6F49A9B1-CB53-4E38-88F3-4D25B395704EQ36075406-00EE465E-A213-4362-AB5E-9732162D745AQ36075611-6957D63A-5280-43A9-9DD3-AC5FE2E2D182Q36075656-02130545-8752-48E8-9C27-DDD4AC44A8B4Q36075882-BF9E8C73-1A21-4D3A-81ED-90A34FA61649Q36076062-61EDA3FE-BAA2-4FBE-827D-122DBF2D8F5AQ36188421-6C14F0EC-C2D7-4620-989B-6FF6F5100FDFQ36405455-AAFB2B29-28F4-46CF-B4AE-4BD89255731BQ36855951-3FE360BF-31F6-4045-87B7-9124106C74E1Q36930395-2D2DBC07-4AD6-434E-BF50-346B277EA8AFQ36944979-0C588B6C-DACE-4B26-A371-1339AFC50F26Q37392831-7AEAF8D7-E91F-4768-8401-D0D4C1D90950Q37488490-7F1F7362-F3C8-4D7A-A004-C16F5D003D06Q38219470-0078340F-0483-4107-A907-037167936F53Q38394472-10EEF6F1-73B8-4355-B83D-3A0ADBFEA41AQ39883226-853608DF-48DE-4F35-9EB7-326144BDD342Q42315864-0E0E37C9-7FCC-4ADB-8678-E66D4027A702Q42335046-44F70293-A45B-46B3-AB4B-F502632DBCB5Q42335054-2A8D974E-C296-4B1F-A78C-38A6624BA9E0Q42335079-FD9EDF25-EBC4-4EBE-9ADD-28D6CC5F3953Q42335083-F9E9356E-A5E8-48A4-8495-A060085754B5Q42844510-A7C798DB-6189-44CC-839E-62BE37110E33Q43000589-C034D16B-1042-4217-A3A5-361B540CF47BQ46618315-053762B1-CBBA-4A63-8966-69A090A429E2Q46731993-31BE7DB4-5394-434E-9588-84274237C01B
P50
name
Delivette Castor
@ast
Delivette Castor
@en
Delivette Castor
@nl
type
label
Delivette Castor
@ast
Delivette Castor
@en
Delivette Castor
@nl
prefLabel
Delivette Castor
@ast
Delivette Castor
@en
Delivette Castor
@nl